BYHEALTH

Forecast & Rating5 analysts currently cover BYHEALTH, with about 80.0% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥11.43, about 10.5% upside from the current price of ¥10.34. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 13.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study BYHEALTH closely still see room for the stock to rise. Data as of Oct 27, 2026; for reference only and not investment advice.